Ekaterina Alexandrova came from behind to defend her 's-Hertogenbosch title in the rain-delayed final on Sunday, battling past fellow Russian...

The highest earning competitive Fortnite players in the US have been revealed. Here's how some of the very best stack up against each other.

Here are our top five wide receiver ratings predictions for Madden NFL 23.

Walter Mazzarri made a winning return as Napoli coach with a hard-fought 2-1 victory at Atalanta pushing the champions up to third...

Randy Meisner was 77 when he died on July 26, 2023, due to complications from Chronic Obstructive Pulmonary Disease

By Timothy Gardner WASHINGTON The Biden administration on Tuesday weakened a rule regulating pollution of waterways to conform

A top Walmart Inc. executive said the retailer remains committed to its Pride Month offerings, even after competitor

One of the scientists whose work pioneered the development of medications such as Ozempic and Wegovy has revealed why life may become “so miserably boring” after two years of using the drug. Ozempic is an FDA-approved medication used for the treatment of type 2 diabetes. It works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), which regulates blood sugar levels and slows down the rate at which food leaves the stomach, often creating the feeling of fullness. These semaglutide injections – sold under the brand names Ozempic and Wegovy – have soared in popularity as many people, including Hollywood celebrities, have used it for weight loss. What’s more, people have also found Ozempic has been effective in curing their addictive habits, like drinking, smoking, shopping, or nail biting. However, because of Ozempic’s increasing popularity, it has led to national shortages of the type 2 diabetes treatment – leaving those who actually need it without. In an interview with Wired, professor Jens Juul Holst – who received the Warren Alpert Foundation Prize in 2021 for his work developing treatments based on the GLP-1 hormone – spoke about the effects of Ozempic, and why he believes many people will stop taking the medication after just a few years. “What happens is that you lose your appetite and also the pleasure of eating, and so I think there’s a price to be paid when you do that,” Holst told Wired. “If you like food, then that pleasure is gone. The craving for food for some people is taken away when they take GLP-1 drugs.” He continued: “That may eventually be a problem, that once you’ve been on this for a year or two, life is so miserably boring that you can’t stand it any longer and you have to go back to your old life.” Holst added that medications like Ozempic and Wegovy have been on the market since 2005, though studies show that these people don’t stay on them for very long. “It’s just like every other drug, they don’t stay on it for many reasons,” he explained. “One of the reasons, as I said, is that once you have tried it and you realise you’ve lost interest in food, then that may be enough.” “We don’t know why people stop taking these drugs, but we know for a fact that they do stop. They do that all over the world.” A 2020 study found that 70 per cent of people who took GLP-1 drugs for type 2 diabetes stopped taking them within two years. However, this could pose a problem for many patients taking semaglutide injections. Research has found that people who stopped taking Ozempic or Wegovy for weight loss experienced weight rebound. A trial published in April 2022 saw participants gain back two thirds of the weight they had lost after 68 weeks of taking semaglutide. As for celebrities who use the once-weekly injection for weight loss, despite not having diabetes or clinical obesity, Hans instead called attention to the “many terrible problems” that those with diabetes have struggled with by not having drugs like Ozempic readily available. “Have you ever visited a diabetes hospital? It’s really deplorable,” he said. “People come in with amputated limbs and compromised cognitive functions and heart problems or they can barely move – they’re miserable and depressed. It’s really serious. There is so much you can improve with a drug that is not only a weight-loss drug but is also an anti-diabetic.” Amidst the popularity of semaglutide injections, the US Food and Drug Administration has issued warnings for consumers not to use off-brand versions of Ozempic or Wegovy, because they may not include the same GLP-1 hormone used in approved medications. Earlier this month, agency officials reported problems with patients using compounded versions of semaglutide – which combines traditional semaglutide with other ingredients. These drugs are not FDA-approved, and the agency does not verify the safety or effectiveness of compounded drugs. Consumers should only use drugs containing semaglutide with a prescription from a licensed health care provider and obtained from a state-licensed pharmacy or other facilities registered with the FDA, the agency said. Read More What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss Pregnant Stassi Schroeder admits she wants to ‘try’ Ozempic after giving birth Doctors warn about ‘Ozempic face’ side effect of medications Amy Schumer says she stopped taking Ozempic because of side-effects

Brad Pitt once revealed his special place for lovemaking in his Los Angeles mansion

There are multiple changes to the tier list thanks to the mid-season Warzone update.

Antarctica might be the only continent on Earth with no natural human habitation, but it’s emerged that an “Antarctica accent” is very much a thing. Despite having no locals, thousands of scientists have made up an ever-changing population in research stations over the years. The continent is so isolated and the level of interaction between researchers is so intense, that a common accent is beginning to emerge there despite people coming from different parts of the world. At its busiest points in the year during the summer, Antarctica is home to around 5,000 people. Only around 1,000 people live there during the winter months. The idea of accents changing due to human interaction on Antarctica is no different to the phenomenon seen throughout history at a glacial pace. However, given the very specific sample size, it’s an opportunity for scientists to study it at a much quicker rate and on a much smaller scale. Experts at the Ludwig Maximilian University of Munich published a study in 2019 which focused on the change in accents observed in 11 people who took part in the British Antarctic Survey. @human.1011 There’s an Antarctic Accent! #language #linguistics #english #antarctica Of the 11 who were studied, eight came from England, one from the US, one from Germany and one from Iceland. Their voices were recorded every six weeks, and the team found that over time they developed longer vowel sounds. There was a physical change too, with participants pronouncing the “ou” sound in the front of their mouths rather than the back of their throats. Speaking to IFL Science, Jonathan Harrington, study author and Professor of Phonetics and Speech Processing at the Ludwig-Maximilians University of Munich said: "The Antarctic accent is not really perceptible as such – it would take much longer for it to become so – but it is acoustically measurable. "It's mostly an amalgamation of some aspects of the spoken accents of the winterers before they went to Antarctica, together with an innovation. It's far more embryonic [than conventional English accents] given that it had only a short time to develop and also, of course, because it's only distributed across a small group of speakers.” Sign up for our free Indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

Idina Menzel was "born singing" but always worried about what others thought of her and tries to connect with others when she performs her signature songs today.